Effects of caerulein on intestinal tract and gallbladder.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002108:Ceruletide / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D005260:Female; D005704:Gallbladder / Q000187:drug effects*; D005765:Gastrointestinal Agents / Q000494:pharmacology*; D005769:Gastrointestinal Motility / Q000187:drug effects; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D007421:Intestine, Small / Q000187:drug effects; D007422:Intestines / Q000187:drug effects*; D008297:Male; D009020:Morphine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009538:Nicotine / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology; D011817:Rabbits; D013779:Tetrodotoxin / Q000494:pharmacology; D014599:Uterus / Q000187:drug effects; D014649:Vas Deferens / Q000187:drug effects
D005765:Gastrointestinal Agents; D010455:Peptides; D013779:Tetrodotoxin; D009538:Nicotine; D009020:Morphine; D001285:Atropine; D002108:Ceruletide; D010830:Physostigmine; D000109:Acetylcholine